The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
JHFH sold some shares two years ago, then bought them back cheaper
And got in on the placing to get lots more shares with his hard earned.
Whats the actual point here? It's all very confusing. JHFH is clearly not a trader. Hes been balls deep for ages and only keeps buying more.
HT, highlighting negative matters as always - even though he's got multimillion shares as a long term holder (obviously you havent). Hit us with a positive post as to why you are invested in HEMO?
HEMO needs you!!
Is that a bite? Why so sad?
Just tell me why you post so negatively? Highlighting perceived shortfalls, SP drops, perpetual failure? Yet millions of shares? I'd be very jealous if it was real!
The rest of your response is dull.
I have to warn you, Im a pretty good judge of character. Its definitely not looking so good for you as things stand. Its like you re 64/8 on a pretty flat deck.
So you honestly feel its necessary to point out the SP is down? I suspect everyone already knew without your prompt.
The CEO doesnt care about the SP so why should I? Not caring would intimate you wouldnt really talk about it. Rather than mock it. In my often misguided opinion. Based on holding millions of shares.
Those of us happy to hold for a year or two are relaxed in the most but still seeing your holdings value reduce is no fun at all and viewed through gritted teeth. But we all know we ride what we hope is short term pain to see some substantial long term gains. But here we are again discussing the daily fluctuation.s.
The CEO is a different matter. I hear your pain in terms of marketing although I a know that as things stand he sees us having nothing to market right now - not to waste money on in any case. Id rather he spent our cash getting the material stages sorted as quick as possible to move CAR T clinical and to further prove up CBR to then tout out to the Pharma world for a partner to take forward.
But the strain on the portfolio is very real. I understand this. I feel it. I just dont see the benefit of a lot of the daily SP commentary I suppose.
Keep on keeping on.
The irony lost on you HT with Vlads tweet?
The tweeter was attacking him. Attempting to sound clever. Ridiculing Vlad and his company.
But can’t even use the correct terminology in his jibe. Rather embarrassing himself.
Is this desperate BS from BS?
Im quite sure not everyone bought at 15p. And im sad for those who did. But I suspect those who see it through will see a profit.
Barbershop cranks his nastiness up and down as necessary for his trades. He wants to buy lower.
"This message has been filtered"
The only poster I have ever blocked. Takes some for me not to want to read what people write.
You dont have the minerals to make a call about anything. Pro after timer.
Do you think the relationship with Eli has ended? Do you think they walked away because it was **** or because they wanted HEMO to prove it up?
If CDX works I say Eli will be back. We work with them on multiple fronts and continue to do so. Maybe you can ask Vlad on the investor call. See how **** Eli think HEMO are?
You wont be on it.
Mr India is having to battle with the compelling investment case of HEMO, particularly at this SP, and needing cash for other matters.
Junior pharma investment is tricky in the sense that you have to have conviction in the company and trust you will end up in the right place over time. Yet you still want to see short term positivity too.
There is no doubt that the big money is made on successful candidates which take time.
Eli say it takes on average 10 years from target to launch. I reckob we are miles ahead of that curve, especially with CAR T which has overtaken the previous primary candidate CDX.
Just to spice things up a bit CBR seems to have the sexy little profile that might draw sizeable investment pre-clinical.
Keep your investment time horizon realistic and the worlds your oyster. Demanding short term turnaround are very unlikely in any circumstances particular pre-clinical and even more so in a bear market.
I hold, try buy a few more when I can, and look forward to future updates. However long it takes!
Everyone knows this already. We are all down. You are bitter?
Do you see the end game? Do you think they will never get there?
COVID really did make things difficult imo. The CLNs were an absolute mess in my view and smashed the SP for investors. The delays have been painful.
But this is junior pharma. HEMO have worked on a shoe string budget. Cashflow is always a constant issue. Delays are inevitable.
But I believe Vlad will make this work. He will make a success of HEMO and produce a successful drug and/or (hopefully and) drug production platform that will be in demand by big pharma and the like.
So whilst slipping timescales are irritating, I am happy to wait. I see progress being made. I see our USP. CBR/HEMO CAR T/CDX are game changers for me. They just have to keep moving things forward to rerate the SP.
I accept it will take as long as it takes. Naively or otherwise. I shall remain patient and confident.
HT, do any of your questions effect whether you buy, hold, or sell stock?
Your whining on LSE smacks of self-doubt in your research.
It comes down to the likelihood of Vlad making something work or not. May of us have made our calls on this. You clearly dont trust Vlad. Id just walk away if I was you, speculating is not for you.
So you can make assumptions on what the Board will and wont have done but no one else can?
Thats how it is!
Why would yo already expect EVE to have run certain scenarios and spreadsheets on cutting costs and seeking profitability over the short term? Do you have any evidence?
Every communication they have issued and it continues up until now is that it is their intention to continue to grow and expand the business. There is nothing that says they seek to go profitable and simply maintain or reduce their turnover with a smaller team. While tout for further investment they wont be looking at cost cutting. However, if the dont get any additional financial input you would think they may start considering how profitability could be hit short term by reducing further costs potentially.
I have a few EVE shares and keep tabs on this chat from time to time.
I cant believe Vlad hasnt made us all millionaires already. We would be now if he'd have done everything when he said. He's useless. Apart from designing all the science. The things we hope will work and be worth billions. Lol.
No other Pharma companies ever have delays. Designing drugs that cure cancer is such a quick and easy job.
All those companies out there who churn out drugs that work every year worth billions zzz
Designing Bio Defense mechanisms to fight viruses known and unknown. All that stuff is so easy too.
Dont even know why Im invested in HEMO. They've got nothing that works and they're taking too long at everything.